查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1713709

2025年獸醫循環系統全球市場報告

Veterinary Cardiology Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年獸醫循環系統市場規模將強勁成長。到 2029 年，這一數字將成長至 43.5 億美元，年複合成長率（CAGR）為 8.8%。預測期內的成長歸因於對獸醫循環系統研究的投資增加、遠距諮詢的遠端醫療服務的擴展、寵物擁有率的成長、消費者對專業獸醫護理的需求增加以及高級獸醫循環系統培訓計畫的增加。預測期內的主要趨勢包括雲端安全解決方案、整合協作平台、對資料隱私和合規性的更多關注、加速向多重雲端環境的遷移以及高度擴充性和靈活的雲端基礎設施解決方案的開發。

寵物和牲畜心臟病發病率的不斷上升預計將在未來幾年推動獸醫循環系統市場的成長。動物的這些心臟疾病會影響心臟的結構和功能，導致血液循環不良、心臟效率降低和潛在的健康併發症。導致寵物和牲畜心臟病增加的因素包括壽命延長、肥胖、營養不良、遺傳因素和缺乏常規獸醫護理。此外，環境壓力和生活條件的變化也可能增加這些動物心血管疾病的發生率。獸醫循環系統在寵物和牲畜心臟病的診斷、治療和管理中發揮著至關重要的作用，透過專門的護理、先進的影像技術和創新程序（包括微創手術）來改善心臟健康和整體生活品質。例如，根據美國獸醫協會2024年3月的報告，黏液瘤性二尖瓣變性（MMVD）是北美最常見的犬類心臟病，佔所有犬類心臟病的75%。據報道，13 歲的小型犬中高達 85% 會出現黏液瘤性二尖瓣疾病的跡象，但這並不一定具有臨床意義。二尖瓣瓣膜閉鎖不全導致的狗心臟病死亡率估計為 40% 至 70%。因此，寵物和牲畜心臟病盛行率的不斷上升將推動獸醫循環系統市場的擴張。

獸醫循環系統領域的主要企業正專注於經導管端到端二尖瓣修復 (TEER) 等技術進步，以增強心臟疾病的治療、改善手術效果並提供微創選擇，以實現更好的康復和生活品質。 TEER 是一種微創手術，透過鉗子解決二尖瓣漏氣問題，以改善瓣膜功能並減輕心臟的壓力。例如，2023 年 2 月，英國獸醫轉診中心 Willows Animal Hospital 為患有黏液瘤性二尖瓣疾病 (MMVD) 的狗推出了一種新的心臟治療方法，這是狗中最常見的心臟疾病。這種治療方法被認為是人類傳統手術的可行替代方案，在狗身上的早期臨床結果也令人鼓舞。進行全身麻醉後，在胸壁上做一個小切口，使用連續的X光和經食道超音波引導針頭到達心尖，從而將 V 型鉗精確放置在二尖瓣上以減少洩漏。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、新冠疫情、經濟復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球獸醫循環系統PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 最終用途產業分析
  • 全球獸醫循環系統市場：成長率分析
  • 全球獸醫循環系統學市場表現：規模與成長，2019-2024
  • 全球獸醫循環系統市場預測：規模與成長，2024-2029 年，2034 年
  • 全球獸醫循環系統總目標市場（TAM）

第6章市場區隔

  • 全球獸醫循環系統市場：依產品、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 製藥
  • 診斷
  • 全球獸醫循環系統市場（按適應症、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • 鬱血性心臟衰竭衰竭
  • 心肌疾病
  • 心律不整
  • 其他適應症
  • 全球獸醫循環系統市場（按動物類型、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • 伴同性動物
  • 生產動物
  • 全球獸醫循環系統市場（按最終用戶、業績和預測），2019-2024 年、2024-2029 年、2034 年
  • 獸醫診所
  • 診所
  • 其他最終用戶
  • 全球獸醫循環系統市場細分（依藥物類型、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • 抗高血壓藥
  • 利尿劑
  • 抗心律不整藥物
  • BETA受體阻斷劑
  • 血管緊張素轉換酶抑制劑
  • 鈣離子通道阻斷劑
  • 正性肌力藥物
  • 有益心臟健康的膳食補充劑
  • 全球獸醫循環系統學市場，診斷細分，按類型、績效和預測，2019-2024 年、2024-2029 年、2034 年
  • 心電圖（ECG）
  • 心臟超音波圖設備
  • 心電圖監測
  • 血壓計
  • 心臟生物標記檢測
  • 胸部X光檢查
  • 超音波設備
  • 心臟監測遠端醫療解決方案

第7章 區域和國家分析

  • 全球獸醫循環系統市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球獸醫循環系統市場：依國家、表現及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章競爭格局與公司概況

  • 獸醫循環系統市場：競爭格局
  • 獸醫循環系統市場：公司簡介
    • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • Zoetis Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Boehringer Ingelheim Animal Health Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

  • Royal Canin
  • IDEXX Laboratories Inc.
  • Ceva Sante Animale SA
  • Fujifilm Healthcare Solutions
  • Dechra Pharmaceuticals PLC
  • Vetoquinol SA
  • ESAOTE SpA
  • SonoScape Medical Corp.
  • Jurox Pty Limited
  • Eickemeyer Veterinary Equipment GmbH
  • VetriScience Laboratories Inc.
  • Bionet America Inc.
  • Scil Animal Care Company
  • Woodley Equipment Company Ltd.
  • Universal Imaging Corporation

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

  • 2029年獸醫循環系統市場：提供新機會的國家
  • 2029年獸醫循環系統市場：細分市場帶來新機會
  • 2029年獸醫循環系統市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第36章 附錄

簡介目錄
Product Code: r33611

Veterinary cardiology is a specialized field of veterinary medicine dedicated to diagnosing and managing heart diseases in animals. This branch ranges from routine examinations to advanced treatments, aiming to enhance pets' quality of life by providing targeted diagnosis and treatment for heart conditions, which leads to better health outcomes and longer lifespans.

The primary product types in veterinary cardiology are pharmaceuticals and diagnostics. Pharmaceuticals refer to the medications used to treat heart conditions in animals, such as managing heart failure, arrhythmias, and other cardiovascular issues. Indications for these medications include congestive heart failure, myocardial disease, arrhythmias, and other heart conditions affecting companion animals and production animals. The end users of these products include veterinary hospitals, clinics, and other related facilities.

The veterinary cardiology market research report is one of a series of new reports from the business research company that provides veterinary cardiology market statistics, including veterinary cardiology industry global market size, regional shares, competitors with an veterinary cardiology market share, detailed veterinary cardiology market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary cardiology industry. This veterinary cardiology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The veterinary cardiology market size has grown strongly in recent years. It will grow from $2.84 billion in 2024 to $3.1 billion in 2025 at a compound annual growth rate (CAGR) of 9.1%. The growth in the historic period can be attributed to increasing pet ownership, growing awareness of pet health, rising prevalence of cardiac disorders in animals, expansion of veterinary specialty clinics, and the increasing availability and affordability of pet insurance.

The veterinary cardiology market size is expected to see strong growth in the next few years. It will grow to $4.35 billion in 2029 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to increasing investment in veterinary cardiology research, expansion of telemedicine services for remote consultations, growth in pet adoption rates, rising consumer demand for specialized veterinary care, and the increasing availability of advanced veterinary cardiology training programs. Major trends in the forecast period include cloud security solutions, integrated collaboration platforms, enhanced focus on data privacy and compliance, accelerated migration to multi-cloud environments, and the development of more scalable and flexible cloud infrastructure solutions.

The increasing incidence of heart diseases in both pets and livestock is anticipated to drive growth in the veterinary cardiology market in the future. These heart conditions in animals impact the heart's structure and functionality, resulting in compromised blood circulation, diminished cardiac efficiency, and possible health complications. Contributing factors to the rise in heart diseases among pets and livestock include longer lifespans, obesity, poor nutrition, genetic factors, and insufficient routine veterinary care. Moreover, environmental stressors and changes in living conditions may also heighten the occurrence of cardiovascular diseases in these animals. Veterinary cardiology plays a crucial role in diagnosing, treating, and managing heart diseases in pets and livestock, utilizing specialized care, advanced imaging techniques, and innovative procedures such as minimally invasive surgeries to enhance heart health and overall quality of life. For example, as reported by the American Veterinary Medical Association in March 2024, Myxomatous mitral valve degeneration (MMVD) is the most common heart disease affecting dogs in North America, accounting for 75% of all canine cardiac conditions. It is noted that 85% of small dogs aged 13 years exhibit signs of a myxomatous mitral valve lesion, although this does not always indicate clinical significance. In MMVD cases, the estimated rate of cardiac-related fatalities in dogs ranges from 40% to 70%. Consequently, the growing prevalence of heart diseases in pets and livestock is set to propel the veterinary cardiology market's expansion.

Leading companies in the veterinary cardiology sector are focusing on technological advancements such as transcatheter edge-to-edge mitral valve repair (TEER) to enhance the treatment of heart diseases, improve surgical outcomes, and provide minimally invasive options for better recovery and quality of life. TEER is a less invasive procedure that addresses mitral valve leakage by using a clamp to improve valve function and reduce heart strain. For instance, in February 2023, Willows Veterinary Centre, a veterinary referral center based in the UK, introduced a novel heart treatment for dogs with myxomatous mitral valve disease (MMVD), the most common heart condition in dogs. This procedure, which is considered a viable alternative to traditional surgery in humans, has shown promising early clinical results in dogs. It involves general anesthesia and a minor chest wall incision, with a needle guided to the heart's apex using continuous X-rays and transesophageal ultrasound to precisely place a V-clamp across the mitral valve to reduce leakage.

In October 2023, EQT AB, a Swedish investment organization, acquired VetPartners for $940 million. This acquisition aligns with EQT's strategy to expand its investment in the animal health sector, aiming to enhance veterinary services and meet the growing demand for animal healthcare. VetPartners, based in the UK, is a veterinary group that offers comprehensive cardiology care and services for animals.

Major companies operating in the veterinary cardiology market are Merck & Co. Inc., Medtronic plc, Siemens Healthineers AG, Zoetis Inc., Boehringer Ingelheim Animal Health, Royal Canin, IDEXX Laboratories Inc., Ceva Sante Animale S.A., Fujifilm Healthcare Solutions, Dechra Pharmaceuticals PLC, Vetoquinol S.A., ESAOTE S.p.A., SonoScape Medical Corp., Jurox Pty Limited, Eickemeyer Veterinary Equipment GmbH, VetriScience Laboratories Inc., Bionet America Inc., Scil Animal Care Company, Woodley Equipment Company Ltd., Universal Imaging Corporation, VetBlue Inc., TeleVet

North America was the largest region in the veterinary cardiology market in 2024. The regions covered in the veterinary cardiology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the veterinary cardiology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The veterinary cardiology market consists of revenues earned by entities by providing services such as educational services, emergency care, telemedicine services, follow-up care, and consultations. The market value includes the value of related goods sold by the service provider or included within the service offering. veterinary cardiology market also includes sales of monitoring devices, treatment products, supportive products, and surgical products. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Veterinary Cardiology Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on veterinary cardiology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for veterinary cardiology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The veterinary cardiology market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Pharmaceuticals; Diagnostics
  • 2) By Indication: Congestive Heart Failure; Myocardial (Heart Muscle) Disease; Arrhythmias; Other Indications
  • 3) By Animal Type: Companion Animals; Production Animals
  • 4) By End-User: Veterinary Hospitals; Clinics; Other End Users
  • Subsegments:
  • 1) By Pharmaceuticals: Antihypertensives; Diuretics; Antiarrhythmic Drugs; Beta Blockers; ACE Inhibitors; Calcium Channel Blockers; Positive Inotropes; Nutraceuticals For Cardiac Health
  • 2) By Diagnostics: Electrocardiograms (ECG); Echocardiography Devices; Holter Monitors; Blood Pressure Monitors; Cardiac Biomarker Tests; Thoracic Radiography; Ultrasound Devices; Telemedicine Solutions for Cardiac Monitoring
  • Companies Mentioned: Merck & Co. Inc.; Medtronic plc; Siemens Healthineers AG; Zoetis Inc.; Boehringer Ingelheim Animal Health
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Veterinary Cardiology Market Characteristics

3. Veterinary Cardiology Market Trends And Strategies

4. Veterinary Cardiology Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Veterinary Cardiology Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Veterinary Cardiology PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Veterinary Cardiology Market Growth Rate Analysis
  • 5.4. Global Veterinary Cardiology Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Veterinary Cardiology Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Veterinary Cardiology Total Addressable Market (TAM)

6. Veterinary Cardiology Market Segmentation

  • 6.1. Global Veterinary Cardiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pharmaceuticals
  • Diagnostics
  • 6.2. Global Veterinary Cardiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Congestive Heart Failure
  • Myocardial (Heart Muscle) Disease
  • Arrhythmias
  • Other Indications
  • 6.3. Global Veterinary Cardiology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Companion Animals
  • Production Animals
  • 6.4. Global Veterinary Cardiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Veterinary Hospitals
  • Clinics
  • Other End Users
  • 6.5. Global Veterinary Cardiology Market, Sub-Segmentation Of Pharmaceuticals, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Antihypertensives
  • Diuretics
  • Antiarrhythmic Drugs
  • Beta Blockers
  • ACE Inhibitors
  • Calcium Channel Blockers
  • Positive Inotropes
  • Nutraceuticals For Cardiac Health
  • 6.6. Global Veterinary Cardiology Market, Sub-Segmentation Of Diagnostics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Electrocardiograms (ECG)
  • Echocardiography Devices
  • Holter Monitors
  • Blood Pressure Monitors
  • Cardiac Biomarker Tests
  • Thoracic Radiography
  • Ultrasound Devices
  • Telemedicine Solutions for Cardiac Monitoring

7. Veterinary Cardiology Market Regional And Country Analysis

  • 7.1. Global Veterinary Cardiology Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Veterinary Cardiology Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Veterinary Cardiology Market

  • 8.1. Asia-Pacific Veterinary Cardiology Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Veterinary Cardiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Veterinary Cardiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Veterinary Cardiology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Veterinary Cardiology Market

  • 9.1. China Veterinary Cardiology Market Overview
  • 9.2. China Veterinary Cardiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Veterinary Cardiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Veterinary Cardiology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Veterinary Cardiology Market

  • 10.1. India Veterinary Cardiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Veterinary Cardiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Veterinary Cardiology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Veterinary Cardiology Market

  • 11.1. Japan Veterinary Cardiology Market Overview
  • 11.2. Japan Veterinary Cardiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Veterinary Cardiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Veterinary Cardiology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Veterinary Cardiology Market

  • 12.1. Australia Veterinary Cardiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Veterinary Cardiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Veterinary Cardiology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Veterinary Cardiology Market

  • 13.1. Indonesia Veterinary Cardiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Veterinary Cardiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Veterinary Cardiology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Veterinary Cardiology Market

  • 14.1. South Korea Veterinary Cardiology Market Overview
  • 14.2. South Korea Veterinary Cardiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Veterinary Cardiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Veterinary Cardiology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Veterinary Cardiology Market

  • 15.1. Western Europe Veterinary Cardiology Market Overview
  • 15.2. Western Europe Veterinary Cardiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Veterinary Cardiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Veterinary Cardiology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Veterinary Cardiology Market

  • 16.1. UK Veterinary Cardiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Veterinary Cardiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Veterinary Cardiology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Veterinary Cardiology Market

  • 17.1. Germany Veterinary Cardiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Veterinary Cardiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Veterinary Cardiology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Veterinary Cardiology Market

  • 18.1. France Veterinary Cardiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Veterinary Cardiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Veterinary Cardiology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Veterinary Cardiology Market

  • 19.1. Italy Veterinary Cardiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Veterinary Cardiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Veterinary Cardiology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Veterinary Cardiology Market

  • 20.1. Spain Veterinary Cardiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Veterinary Cardiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Veterinary Cardiology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Veterinary Cardiology Market

  • 21.1. Eastern Europe Veterinary Cardiology Market Overview
  • 21.2. Eastern Europe Veterinary Cardiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Veterinary Cardiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Veterinary Cardiology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Veterinary Cardiology Market

  • 22.1. Russia Veterinary Cardiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Veterinary Cardiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Veterinary Cardiology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Veterinary Cardiology Market

  • 23.1. North America Veterinary Cardiology Market Overview
  • 23.2. North America Veterinary Cardiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Veterinary Cardiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Veterinary Cardiology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Veterinary Cardiology Market

  • 24.1. USA Veterinary Cardiology Market Overview
  • 24.2. USA Veterinary Cardiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Veterinary Cardiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Veterinary Cardiology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Veterinary Cardiology Market

  • 25.1. Canada Veterinary Cardiology Market Overview
  • 25.2. Canada Veterinary Cardiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Veterinary Cardiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Veterinary Cardiology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Veterinary Cardiology Market

  • 26.1. South America Veterinary Cardiology Market Overview
  • 26.2. South America Veterinary Cardiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Veterinary Cardiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Veterinary Cardiology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Veterinary Cardiology Market

  • 27.1. Brazil Veterinary Cardiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Veterinary Cardiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Veterinary Cardiology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Veterinary Cardiology Market

  • 28.1. Middle East Veterinary Cardiology Market Overview
  • 28.2. Middle East Veterinary Cardiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Veterinary Cardiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Veterinary Cardiology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Veterinary Cardiology Market

  • 29.1. Africa Veterinary Cardiology Market Overview
  • 29.2. Africa Veterinary Cardiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Veterinary Cardiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Veterinary Cardiology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Veterinary Cardiology Market Competitive Landscape And Company Profiles

  • 30.1. Veterinary Cardiology Market Competitive Landscape
  • 30.2. Veterinary Cardiology Market Company Profiles
    • 30.2.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Zoetis Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Boehringer Ingelheim Animal Health Overview, Products and Services, Strategy and Financial Analysis

31. Veterinary Cardiology Market Other Major And Innovative Companies

  • 31.1. Royal Canin
  • 31.2. IDEXX Laboratories Inc.
  • 31.3. Ceva Sante Animale S.A.
  • 31.4. Fujifilm Healthcare Solutions
  • 31.5. Dechra Pharmaceuticals PLC
  • 31.6. Vetoquinol S.A.
  • 31.7. ESAOTE S.p.A.
  • 31.8. SonoScape Medical Corp.
  • 31.9. Jurox Pty Limited
  • 31.10. Eickemeyer Veterinary Equipment GmbH
  • 31.11. VetriScience Laboratories Inc.
  • 31.12. Bionet America Inc.
  • 31.13. Scil Animal Care Company
  • 31.14. Woodley Equipment Company Ltd.
  • 31.15. Universal Imaging Corporation

32. Global Veterinary Cardiology Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Veterinary Cardiology Market

34. Recent Developments In The Veterinary Cardiology Market

35. Veterinary Cardiology Market High Potential Countries, Segments and Strategies

  • 35.1 Veterinary Cardiology Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Veterinary Cardiology Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Veterinary Cardiology Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
  • 250423_r33611_Veterinary_Cardiology_GMR_2025